RA Capital Management’s SAB Biotherapeutics SABS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-237,408	Closed	-$1.63M	–	78
2023 Q4	$1.63M	Buy	+237,408	New	+$1.63M	0.03%	61